Search

Your search keyword '"Liem, Anho"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Liem, Anho" Remove constraint Author: "Liem, Anho"
184 results on '"Liem, Anho"'

Search Results

1. Treatment of elderly patients with non-ST-elevation myocardial infarction: the nationwide POPular age registry

3. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

6. Treatment of elderly patients with non-ST-elevation myocardial infarction: the nationwide POPular age registry

9. Acute cardioversion vs a wait-and-see approach for recent-onset symptomatic atrial fibrillation in the emergency department: Rationale and design of the randomized ACWAS trial

10. Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

13. High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome: BIOMArCS Study

20. Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission

21. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

22. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

23. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

24. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

25. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

26. Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation

27. Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2)

28. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

29. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial

32. Afname van de proportie schokbare beginritmes bij reanimaties buiten het ziekenhuis in Nederland

33. De psychologische impact na een reanimatie door burgerhulpverleners

36. Overleving na een reanimatie buiten het ziekenhuis: vergelijking van de resultaten van 6 verschillende Nederlandse regio's

37. AED-inzet als onderdeel van de zorgketen

38. Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure

39. Trends in comorbidity in patients hospitalised for cardiovascular disease

40. Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality

41. Cohort profile of BIOMArCS : the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands

43. Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands

44. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes

45. Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands

47. Leucocyte‐bound apolipoprotein B in the circulation is inversely associated with the presence of clinical and subclinical atherosclerosis

49. PERFORMANCE OF CARDIAC CT COMPARED TO FUNCTIONAL TESTING IN WOMEN AND MEN WITH SUSPECTED CORONARY ARTERY DISEASE: THE MULTICENTER, RANDOMIZED CRESCENT TRIAL

Catalog

Books, media, physical & digital resources